A Seoul National University Bundang Hospital (SNUBH) research team has identified the specific genotypes in Koreans that affect the onset of congenital non-progressive night blindness symptoms for the first time.Night blindness refers to the symptom of being unable to discern objects in the dark bec
Humedix has partnered up with a U.S. immuno-oncology developer Kineta to strengthen its CMO business and secure funding for future growth.The company said Tuesday that it has recently decided to sign a strategic investment deal with Kineta, acquiring 1.56 percent of the latter’s Kineta's shares wort
MSD released positive results from a phase 3 study of molnupiravir, an investigational pill to treat Covid-19, drawing attention from the pharmaceutical market.On Tuesday, Kyobo Securities published a monthly report to explain the meaning of the launch of Covid-19 oral treatments.Kim Jeong-hyeon, a
Roche Korea said Tuesday that it would expand the company’s neuroscience unit by receiving approval for its two mental disorder treatments -- Evrysdi (ingredient: risdiplam) and Enspryng (satralizumab) -- in five years.The company also stressed the importance of treating rare diseases, such as spina
The government said Tuesday nine out of 10 adults have received at least one shot of the Covid-19 vaccine, helping the nation to transit to a "live-with-covid" system."Considering that the target of vaccination in Korea so far has been adults over the age of 18, 90 percent of the people eligible for
One of the reasons for vaccine hesitancy is worries about adverse reactions.Some people in Korea have developed various “vaccine detoxification methods,” claiming they remove or reduce the Covid-19 vaccines’ ill effects.These controversial methods include cupping treatment, intentionally bruising th
AbbVie’s JAK inhibitor Rinvoq (upadacitinib) showed a faster therapeutic effect than Sanofi’s Dupixent (dupilumab) in evaluations of body regions (head and neck, trunk, upper limbs, and lower limbs) of patients with moderate to severe atopic dermatitis.On Thursday, AbbVie released the new analysis o
A research team at Seoul National University Bundang Hospital (SNUBH) has confirmed that smoking e-cigarettes increases the risk of cardiovascular disease compared to those who do not smoke.Some smokers quit regular cigarettes and start using e-cigarettes as they believe that the latter has relative
Takeda Korea's oral treatment Ninlaro (ingredient: ixazomib) has won approval from the Ministry of Food and Drug Safety as maintenance therapy for patients with multiple myeloma who did not receive autologous hematopoietic stem cell transplant.Ninlaro became the first domestic oral proteasome inhibi
Celltrion said that it has submitted a marketing authorization application (MAA) of Regkirona, a Covid-19 treatment, to the European Medicines Agency (EMA) last Friday.“The indication target is adult patients 18 years of age or older confirmed with Covid-19 who do not require supplemental oxygen sup
Sudanese Minister of Investment and International Cooperation Al-Hadi Ibrahim and Industry Minister Ibrahim al-Sheikh visited Shinpoong Pharmaceutical last Friday to discuss the company’s role in developing the African country’s pharmaceutical industry.During the visit, the two ministers toured the
Spectrum Pharmaceuticals, a U.S. partner company of Hanmi Pharmaceutical, will hold a Type-A meeting with the FDA to win approval for Rolontis (eflapegrastim), a treatment for neutropenia.Through a Type-A meeting, a company can take the feedback from the FDA and address issues impeding drug approval
The Korean Society for Laboratory Medicine (KSLM) expressed concerns over the increasing number of people purchasing home antibody kits at pharmacies and taking Covid-19 antibody tests.Home antibody tests are inaccurate and ineffective, and they can evaluate neither a person’s immunity against the C
The K-Hospital Fair has completed its three-day event, introducing various sustainable, innovative digital healthcare solutions amid the prolonged Covid-19 pandemic and accelerating the digitization of the healthcare industry.Many Korean and foreign biotech companies developing digital healthcare so
CartiLife, an autologous cartilage-derived chondrocyte cell therapy for regenerating knee cartilage, will be easier to inject with a new injector, industry officials said.CartiLife won a conditional nod from the Ministry of Food and Drug Safety in April 2019 to treat knee cartilage defects (ICRS Gra
The domestic botulinum toxin (BTX) drug market is going through significant changes in terms of production and import, government and business officials said.According to the Ministry of Food and Drug Safety Friday, the production and import of 17 BTX drugs, including Botox, Botulax, Medytoxin, and
Celltrion has submitted an application to obtain approval for CT-P16, a biosimilar of Roche's Avastin (ingredient: bevacizumab), for colorectal cancer treatment in the U.S. and Korea.The company completed global clinical trials of CT-P16 at 150 cites in 20 countries in Europe, South America, and Asi
The government said Friday it would secure sufficient healthcare capacity first to move to the “live-with-covid” system from November.It was the first time that the government officially set its timeline to shift to the relaxed quarantine system, in which most restrictions are eased with officials f
Global pharmaceutical companies’ investment in R&D in Korea has continued to rise for the fifth consecutive year in 2020, an industry group report showed.The number of early clinical trials and studies of cancer and rare diseases increased significantly, and employment for R&D also expanded steadily
Merck’s oral antiviral treatment for Covid-19, molnupiravir, has reportedly shown potential efficacy on the variants of the Covid-19 virus, causing Korean companies to speed up efforts to develop similar oral medicines.Merck, or MSD in the U.S. and Canada, said Wednesday its experimental Covid-19 th